is another humanized IgG4 anti-CD47 antibody that inhibits CD47-SIRPα interaction and enabled phagocytosis in cancer cell lines, including hematological cancer cell lines, as well as in solid tumor xenografts [69]. This evidence concerns the gene CD47 and hematopoietic and lymphoid cell neoplasm.